» Authors » Charles van Heyningen

Charles van Heyningen

Explore the profile of Charles van Heyningen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 184
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hopkins P, Defesche J, Fouchier S, Bruckert E, Luc G, Cariou B, et al.
Circ Cardiovasc Genet . 2015 Sep; 8(6):823-31. PMID: 26374825
Background: Patients with PCSK9 gene gain of function (GOF) mutations have a rare form of autosomal dominant hypercholesterolemia. However, data examining their clinical characteristics and geographic distribution are lacking. Furthermore,...
2.
Chadwick C, van Heyningen C
BMJ . 2013 Feb; 346:f647. PMID: 23390229
No abstract available.
3.
van Heyningen C, Glaysher J
Curr Opin Lipidol . 2012 Nov; 23(6):584-5. PMID: 23160404
No abstract available.
4.
Wong P, Rao G, Innasimuthu A, Saeed Y, van Heyningen C, Robinson D
Coron Artery Dis . 2010 Jul; 21(6):363-8. PMID: 20661138
Objective: Serum cardiac troponins can be elevated in acute coronary syndromes (ACS) and other non-ACS conditions. We investigated the usefulness of a prediction score model comprising clinical variables to distinguish...
5.
van Heyningen C
Curr Opin Lipidol . 2009 Sep; 20(5):440-1. PMID: 19741339
No abstract available.
6.
7.
van Heyningen C, Simms D
Ann Clin Biochem . 2008 Sep; 45(Pt 6):610-1. PMID: 18782811
A 47-year-old man presented with abdominal pain, neck stiffness, severe transient hypertension and unusually dark urine. Cerebrospinal fluid investigations and angiography confirmed the diagnosis of a subarachnoid haemorrhage. Porphyrin studies...
8.
Wood K, van Heyningen C
Ann Clin Biochem . 2008 Sep; 46(Pt 1):82. PMID: 18782810
No abstract available.
9.
van Heyningen C
Curr Opin Lipidol . 2007 Jul; 18(4):470-2. PMID: 17620865
No abstract available.
10.
Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I, et al.
Clin Endocrinol (Oxf) . 2006 Aug; 65(2):246-9. PMID: 16886968
Objective: To determine the characteristics, causes and outcome of severe hyponatraemia (< 125 mmol/l) in hospitalized patients, and to identify mortality predictors. Design: Prospective case controlled study of sequentially presenting...